Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dubédat

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neuroscience Letters|July 28, 1995
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmissionA Boireau, F Bordier, P Dubédat, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1988
Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in ratE Hétier, A Boireau, P Dubédat, et al.
Neuroscience Letters|November 19, 1997
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in miceA Boireau, F Bordier, P Dubédat, et al.
Neuroreport|October 27, 1994
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivoA Boireau, J M Miquet, P Dubédat, et al.
European Journal of Pharmacology|September 25, 1995
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot studyA Benazzouz, T Boraud, P Dubédat, et al.
Neuroscience Letters|July 25, 2000
The anti-oxidant ebselen antagonizes the release of the apoptogenic factor cytochrome c induced by Fe2+/citrate in rat liver mitochondriaA Boireau, P M Maréchal, M Meunier, et al.
Journal of Neurochemistry|May 1, 1991
Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neuronsM N Castel, D Faucher, F Cuiné, et al.
Biochemical Pharmacology|October 1, 1988
In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellumA Boireau, M Martel, G Farges, et al.
Neuroscience|October 1, 1996
Neuroprotective effects of riluzole on a model of Parkinson's disease in the ratP Barnéoud, M Mazadier, J M Miquet, et al.
Neuroreport|December 20, 1994
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in miceA Boireau, P Dubédat, F Bordier, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuroscience Letters|July 28, 1995
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmissionA Boireau, F Bordier, P Dubédat, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1988
Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in ratE Hétier, A Boireau, P Dubédat, et al.
Neuroscience Letters|November 19, 1997
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in miceA Boireau, F Bordier, P Dubédat, et al.
Neuroreport|October 27, 1994
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivoA Boireau, J M Miquet, P Dubédat, et al.
European Journal of Pharmacology|September 25, 1995
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot studyA Benazzouz, T Boraud, P Dubédat, et al.
Neuroscience Letters|July 25, 2000
The anti-oxidant ebselen antagonizes the release of the apoptogenic factor cytochrome c induced by Fe2+/citrate in rat liver mitochondriaA Boireau, P M Maréchal, M Meunier, et al.
Journal of Neurochemistry|May 1, 1991
Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neuronsM N Castel, D Faucher, F Cuiné, et al.
Biochemical Pharmacology|October 1, 1988
In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellumA Boireau, M Martel, G Farges, et al.
Neuroscience|October 1, 1996
Neuroprotective effects of riluzole on a model of Parkinson's disease in the ratP Barnéoud, M Mazadier, J M Miquet, et al.
Neuroreport|December 20, 1994
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in miceA Boireau, P Dubédat, F Bordier, et al.
Pageof 2